(firstQuint)Treatment of Patients With Lesions in the Superficial Femoral or Popliteal Arteries Using Kanshas Drug Coated Balloon.

 The KANSHAS 1 (K-1) trial investigates the inhibition of restenosis using the Kanshas DCB in the treatment of de novo lesions in the superficial femoral or popliteal arteries.

 The proposed clinical study will be a prospective, multi-center, controlled, open, single-arm study.

 Up to 50 patients will be enrolled at up to 7 sites in Belgium and Germany.

 Follow-ups are scheduled before discharge, at 30 days, 6 months, 1, and 2 years.

 Each patient will have a follow-up contact via hospital visit and telephone.

.

 Treatment of Patients With Lesions in the Superficial Femoral or Popliteal Arteries Using Kanshas Drug Coated Balloon@highlight

To assess safety and efficacy of the Kanshas DCB in the treatment of de novo lesions in the superficial femoral (SFA) and/or popliteal arteries.

